What drove the IGPH.SW stock move on 06 Jan 2026?

The IGPH.SW stock fall to CHF0.0015 reflected heavy volume of 2,033,000 shares and low liquidity. The session’s large relative volume of 10.48 amplified selling pressure and highlighted short-term execution risk for small-cap healthcare stocks.

What is Meyka AI’s rating for IGPH.SW stock?

Meyka AI rates IGPH.SW with a score of 61.95, grade B and suggestion HOLD. The grade factors in benchmarks, sector and financial metrics and is informational, not financial advice.

What price target and outlook exist for IGPH.SW stock?

Meyka AI's forecast model projects a 12-month target of CHF0.0050 for IGPH.SW stock, implying a potential upside of +233.33% from CHF0.0015. Forecasts are model-based projections and not guarantees.

What are the key risks for IGPH.SW stock investors?

Key risks for IGPH.SW stock include balance-sheet strain, negative EPS, potential dilution, one full-time employee, and thin liquidity. These factors increase volatility and execution risk for holders and traders.

CH Stocks

CHF0.0015 close: IGPH.SW stock most active on SIX 06 Jan 2026: liquidity note

ByDanny Kontos January 7, 2026January 7, 2026

IGPH.SW stock closed at CHF0.0015 on SIX on 06 Jan 2026 after a -25.00% intraday drop, driven by a large active session. Volume surged to 2,033,000 shares versus an average of 193,941, giving a relative volume of 10.48. The move put liquidity and dilution risk in focus for IGEA Pharma N.V. (IGPH.SW). We use trading, fundamentals and sector context to explain the session and what it means for short- and medium-term holders.